Position in ELAN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$543,167
+$37,072 QoQ
Shares Held
22,071
+4.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#276
of 515 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Kera Capital Partners, Inc. holds $1,161,091 across 4 Drug Manufacturers - Specialty & Generic names. ELAN ranks #1 (46.8% of the industry book) .
All Filings in ELAN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $543,167 | 22,071 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $506,095 | 21,149 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $491,863 | 21,735 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $244,499 | 12,140 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $169,460 | 11,867 | Shares | Sole | 2025-07-01 | |
| No filing history on record for this holder in this stock. | ||||||